References - Cardiovascular System

1. Adenosine Dose: South African Medicines Formulary (SAMF), 13th Edition. Division of Pharmacology, Faculty of Health Sciences, University of Cape Town. 2020.
2. Kleinman ME, et.al. Pediatric Life Support: Part 14. Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010; 122: S876-S908.
3. Barrington KJ. The Myth of a Minimum Dose for Atropine. Pediatrics. 2011;127 (4): 783-784. http://pediatrics.aappublications.org/content/127/4/783.full
4. Shann F. Drug Doses. 16th Edition. 2014.
5. Leversha AM. Efficacy and dosage of enalapril in congenital and acquired heart disease. Archives of Disease in Childhood. 1994; 70(1):35-39.
6. Shaw N, et. al. Captopril in heart failure secondary to left to right shunt. Archives of Disease in Childhood. 1988, 65:360-363.
7. The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European society of Cardiology. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis. European Heart Journal. 2009;30:2369-2413.
8. Dahl A, et. al. Enterococcus faecalis Infective Endocarditis: A pilot study of the relationship between duration of gentamicin treatment and outcome. Circulation. 2013;127:1810-1817.
9. Wilson WR et.al. Prevention of Viridans Group Streptococcal Infective Endocarditis. A Scientific Statement from the American Heart Association. Circulation. 2021, 143: e963-e978.
10. RHD Australia. The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease, 3rd Edition. 2020. https://www.rhdaustralia.org.au/arf-rhd-guideline
11. Gerber MA, et.al. Prevention of Rheumatic Fever and Diagnosis and Treatment of Acute Streptococcal Pharyngitis. American Heart Association Statement. Circulation. 2009;119:1541-1551.
12. Robinson J, Hartling L, Vandermeer B, Sebastianski M, Klassen TP. Intravenous immunoglobulin for presumed viral myocarditis in children and adults. Cochrane Database of Systematic Reviews 2020, Issue 8. Art. No.: CD004370. DOI: 10.1002/14651858.CD004370.pub4.
13. Mayosi BM, et. al. Prednisolone and Mycobacterium indicus pranii in Tuberculous Pericarditis. NEJM. 2014; 371: 1121-1130.
14. Strang JIG, et.al. Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei. The Lancet. 1987. 330; 8573:1418-1422.
15. Kantor PF. Clinical Practice - Heart failure in children. Part I: clinical evaluation, diagnostic testing, and initial management. Eur J Pediatr. 2010, 169: 269-279.
16. Kantor PF. Clinical Practice - Heart failure in children. Part II: current maintenance therapy and new therapeutic approaches. Eur J Pediatr. 2010, 169: 403-410.
17. Capoten® Package Insert. Bristol-Myers Squibb. 2014.
18. Lasix® Package Insert. Sanofi-Aventis. 2012.
19. Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics. 2017;140(3):e20171904
20. Whitelock RP, et. al. Antithrombotic and Thrombolytic Therapy for Valvular Disease. Antithrombotic Therapy and Prevention of Thrombosis 9th Edition. CHEST. 2012; 141 (2): e576S-e600S.

---

Standard Treatment Guidelines And Essential Medicines List For South Africa, Hospital Level, Paediatrics, 2023 Edition

Chapter 4: Cardiovascular System, References